Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases

Isabelle Durand-Zaleski; Béatrice Roche; Marc Buyse; Robert Carlson; Michael O'Connell; Philippe Rougier; Alfred E. Chang; Vernon K. Sondak; Margaret Kemeny; Tim Allen-Mersh; Pierre Louis Fagniez; Jean Paul Le Bourgeois; Pascal Piedbois

doi:10.1016/S1040-8428(99)00043-8

Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases

Isabelle Durand-Zaleski, Béatrice Roche, Marc Buyse, Robert Carlson, Michael O'Connell, Philippe Rougier, Alfred E. Chang, Vernon K. Sondak, Margaret Kemeny, Tim Allen-Mersh, Pierre Louis Fagniez, Jean Paul Le Bourgeois, Pascal Piedbois

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Original language	English
Pages (from-to)	125-131
Number of pages	7
Journal	Critical Reviews in Oncology/Hematology
Volume	32
Issue number	2
DOIs	https://doi.org/10.1016/S1040-8428(99)00043-8
State	Published - Nov 1999
Externally published	Yes

Access to Document

10.1016/S1040-8428(99)00043-8

Cite this

Durand-Zaleski, I., Roche, B., Buyse, M., Carlson, R., O'Connell, M., Rougier, P., Chang, A. E., Sondak, V. K., Kemeny, M., Allen-Mersh, T., Fagniez, P. L., Le Bourgeois, J. P., & Piedbois, P. (1999). Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases. Critical Reviews in Oncology/Hematology, 32(2), 125-131. https://doi.org/10.1016/S1040-8428(99)00043-8

@article{d516ce79204349998066b50f873c8d92,

title = "Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases",

author = "Isabelle Durand-Zaleski and B{\'e}atrice Roche and Marc Buyse and Robert Carlson and Michael O'Connell and Philippe Rougier and Chang, {Alfred E.} and Sondak, {Vernon K.} and Margaret Kemeny and Tim Allen-Mersh and Fagniez, {Pierre Louis} and {Le Bourgeois}, {Jean Paul} and Pascal Piedbois",

year = "1999",

month = nov,

doi = "10.1016/S1040-8428(99)00043-8",

language = "English",

volume = "32",

pages = "125--131",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

Durand-Zaleski, I, Roche, B, Buyse, M, Carlson, R, O'Connell, M, Rougier, P, Chang, AE, Sondak, VK, Kemeny, M, Allen-Mersh, T, Fagniez, PL, Le Bourgeois, JP & Piedbois, P 1999, 'Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases', Critical Reviews in Oncology/Hematology, vol. 32, no. 2, pp. 125-131. https://doi.org/10.1016/S1040-8428(99)00043-8

Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases. / Durand-Zaleski, Isabelle; Roche, Béatrice; Buyse, Marc et al.
In: Critical Reviews in Oncology/Hematology, Vol. 32, No. 2, 11.1999, p. 125-131.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases

AU - Durand-Zaleski, Isabelle

AU - Roche, Béatrice

AU - Buyse, Marc

AU - Carlson, Robert

AU - O'Connell, Michael

AU - Rougier, Philippe

AU - Chang, Alfred E.

AU - Sondak, Vernon K.

AU - Kemeny, Margaret

AU - Allen-Mersh, Tim

AU - Fagniez, Pierre Louis

AU - Le Bourgeois, Jean Paul

AU - Piedbois, Pascal

PY - 1999/11

Y1 - 1999/11

UR - http://www.scopus.com/inward/record.url?scp=0032702228&partnerID=8YFLogxK

U2 - 10.1016/S1040-8428(99)00043-8

DO - 10.1016/S1040-8428(99)00043-8

M3 - Article

C2 - 10612012

AN - SCOPUS:0032702228

SN - 1040-8428

VL - 32

SP - 125

EP - 131

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

IS - 2

ER -